リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「D-Allulose Improves Endurance and Recovery from Exhaustion in Male C57BL/6J Mice」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

D-Allulose Improves Endurance and Recovery from Exhaustion in Male C57BL/6J Mice

刘, 冰阳 名古屋大学

2022.07.26

概要

【Introduction】
D-Allulose is a rare, functional sugar formed by the epimerization of D-fructose at the C-3 position, which has been shown to ameliorate insulin resistance and glucose tolerance in rodents and humans and reduce abdominal fat accumulation in rodents and humans. It has been reported that daily intake of D-allulose may accelerate the repletion of liver and muscle glycogen after exhaustive swimming. Long-term administration of a rare sugar syrup containing D-allulose enhanced the translocation of liver glucokinase and increased liver glycogen content. In addition, others showed that D-allulose promoted fat oxidation, and enhancement of postprandial fat oxidation in response to D-allulose intake has also been reported in healthy humans.
We hypothesized that D-allulose would enhance exercise performance because its administration has been shown to increase muscle or liver glycogen storage and fat oxidation. In the present study, we assessed whether D-allulose administration improves endurance ability and accelerates recovery from exhaustion. We further compared the effects of D-allulose with exercise training effects to understand its mechanism of action.

【Materials and Methods】
Six-week-old male C57BL/6J mice were singly housed in cages and allowed free access to a standard chow diet (MF powders) and water from the period of environmental adaptation until the beginning of the experiment. During the intervention period, mice were either kept on the chow diet (AIN93G powder, including 3% cellulose) or a D-allulose diet (AIN93G powder, including 3% D-allulose). To standardize the number of calories in the diets, D-allulose was replaced with cellulose. A free-wheel running apparatus was placed into individual cages housing mice assigned to exercise, and the mice were allowed to run freely on the wheels. Food intake was measured once every 2 days. Body weights were measured weekly.
1. Experiment 1: Effect of Long-Term D-Allulose Administration on Aerobic Performance (Figure 1)
Mice were randomly assigned into two groups: a chow diet group (E1 group, n = 6) and a D-allulose diet group (AE1 group, n = 7). Running wheels were placed in all cages. All mice performed the first endurance and recovery tests on a chow diet. The second endurance and recovery tests were performed after 4 weeks of administration of either a chow diet or a D-allulose diet.
2. Experiment 2: Effect of Long-Term D-Allulose Administration on Maximal Aerobic Speed and Physiological Indicators Related to Aerobic Performance (Figure 2)
Ten-week-old mice were divided into four groups: sedentary/chow diet group (C2, n = 6), sedentary/D-allulose group (A2, n = 6), exercise/chow diet group (E2, n = 6), and exercise/D-allulose group (AE2, n = 7). Mice in the exercise groups (E2 and AE2) had free access to the wheel after the grouping at the start of Week 3. The first MAS and BGL tests were performed before the grouping. The second tests and ipGTT were conducted 4 weeks after the grouping. Mice were euthanized by cervical dislocation immediately after running on the treadmill at 20 m/min for 30 min at the end of Week 8. Muscles and liver were immediately removed and subsequently frozen in liquid nitrogen for further analysis (liver and muscle glycogen levels, western blots).
3. Experiment 3: Effect of Short-Term D-Allulose Administration on MAS, Blood Glucose, and Blood Lactate Levels (Figure 3)
Mice (n = 6) were on an alternate feeding regimen of chow diet or D-allulose. We measured both glucose and lactate levels before and after each MAS test.

【Results】
1. Experiment 1
D-Allulose Improves Endurance and Recovery. (Figure 4).
2. Experiment 2
D-Allulose administration increased the maximal aerobic speed (MAS)(Figure 5). D- Allulose also suppressed blood lactate increase after 2 hours running (Figure 6). Although D-allulose did not change the overall glucose levels as determined by ipGTT, it decreased plasma insulin levels, indicating enhanced insulin sensitivity (Figure 7). D-Allulose and exercise intervention did not significantly affect liver and muscle weight in mice, but significantly reduced white fat weight, and the combination of the two further enhanced this effect (Table 1). D-Allulose increased liver glycogen but not muscle glycogen levels (Figure 8). Finally, D-allulose enhanced the phosphorylation of AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) and the expression of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) (Figure 9).
3. Experiment 3
D-Allulose administration increased the MAS and suppressed blood lactate increase after the MAS test, which was even observed following treatment for >3 or 7 days (Figure 10).

【Discussion】
The effects of D-allulose on aerobic exercise performance can depend on the availability of carbohydrates and fat, which are the main sources for ATP production. Glycogen contents in the muscles and liver are associated with endurance and recovery from exhaustive exercise. In our study, both the voluntary running distance and the MAS increased after short-term administration of D-allulose. These effects of D-allulose may be due to increased levels of liver glycogen. However, D-allulose can also impact exercise performance through changes in fat oxidation.
Lipids are another primary source for the production of ATP. During muscle contraction, the uptake of fatty acids in skeletal muscle increases, while the activity of ACC decreases, which promotes the phosphorylation of ACC. PGC-1α is involved in the regulation of energy metabolism and mitochondrial biogenesis. Long-term aerobic exercise training significantly affects the AMPK-PGC-1α pathway. We found that D-allulose administration enhanced the AMPK axis, which is consistent with D-allulose enhancing the oxidation of fatty acids. A strong fat-oxidation ability increases the endurance exercise capacity.
The accumulation of blood lactate indicates the aerobic/anaerobic transition and is an important marker for endurance exercise capacity. In the present study, blood lactate levels after 2 h of endurance running at moderate intensity were lower after 4 weeks of D-allulose administration or exercise training. As the intensity of endurance running was likely to be below the lactate threshold levels, the difference in lactate levels is possibly because of the improved utilization of fatty acid rather than the increased synthesis of lactate. In the MAS test, even short-term administration (e.g., 3 days) of D-allulose effectively reduced lactate levels after running. As lactate levels are expected to increase if increased liver glycogen is driving the improvement in MAS, we speculate that the improvement in MAS can be, at least in part, because of improved fat oxidation. Blood glucose levels significantly decreased during the period of chow diet administration but not during the D- allulose administration period, which suggests that D-allulose administration increased glycogen levels or the preferred use of free fatty acid.

【Conclusion】
The present data indicated that D-allulose can prevent fatigue during or after exercise. Our study not only provides valuable insights into the potential role of D-allulose in alleviating obesity and enhancing aerobic exercise performance in humans but also conclusively establishes a viable and promising option to ameliorate the clinical outcomes of obesity-induced health problems by using D-allulose.

参考文献

1. Nimptsch, K.; Konigorski, S.; Pischon, T. Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism 2019, 92, 61–70. [CrossRef] [PubMed]

2. Kirwan, J.P.; Sacks, J.; Nieuwoudt, S. The essential role of exercise in the management of type 2 diabetes. Cleve Clin. J. Med. 2017, 84 (Suppl. 1), S15–S21. [CrossRef] [PubMed]

3. Hossain, A.; Yamaguchi, F.; Matsuo, T.; Tsukamoto, I.; Toyoda, Y.; Ogawa, M.; Nagata, Y.; Tokuda, M. Rare sugar D-allulose: Potential role and therapeutic monitoring in maintaining obesity and type 2 diabetes mellitus. Pharmacol. Ther. 2015, 155, 49–59. [CrossRef]

4. Mu, W.M.; Zhang, W.L.; Feng, Y.H.; Jiang, B.; Zhou, L. Recent advances on applications and biotechnological production of d-psicose. Appl. Microbiol. Biot. 2012, 94, 1461–1467. [CrossRef]

5. Natsume, Y.; Yamada, T.; Iida, T.; Ozaki, N.; Gou, Y.; Oshida, Y.; Koike, T. Investigation of D-allulose effects on high-sucrose diet-induced insulin resistance via hyperinsulinemic-euglycemic clamps in rats. Heliyon 2021, 7, e08013. [CrossRef]

6. Gou, Y.; Liu, B.Y.; Cheng, M.Y.; Yamada, T.; Iida, T.; Wang, S.X.; Banno, R.; Koike, T. D-Allulose Ameliorates Skeletal Muscle Insulin Resistance in High-Fat Diet-Fed Rats. Molecules 2021, 26, 6310. [CrossRef]

7. Shintani, T.; Yamada, T.; Hayashi, N.; Iida, T.; Nagata, Y.; Ozaki, N.; Toyoda, Y. Rare Sugar Syrup Containing D-Allulose but Not High-Fructose Corn Syrup Maintains Glucose Tolerance and Insulin Sensitivity Partly via Hepatic Glucokinase Translocation in Wistar Rats. J. Agric. Food Chem. 2017, 65, 2888–2894. [CrossRef]

8. Hossain, M.A.; Kitagaki, S.; Nakano, D.; Nishiyama, A.; Funamoto, Y.; Matsunaga, T.; Tsukamoto, I.; Yamaguchi, F.; Kamitori, K.; Dong, Y.; et al. Rare sugar D-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Biochem. Biophys. Res. Commun. 2011, 405, 7–12. [CrossRef]

9. Lee, D.; Han, Y.; Kwon, E.Y.; Choi, M.S. D-allulose Ameliorates Metabolic Dysfunction in C57BL/KsJ-db/db Mice. Molecules 2020, 25, 3656. [CrossRef] [PubMed]

10. Han, Y.; Kwon, E.Y.; Choi, M.S. Anti-Diabetic Effects of Allulose in Diet-Induced Obese Mice via Regulation of mRNA Expression and Alteration of the Microbiome Composition. Nutrients 2020, 12, 2113. [CrossRef]

11. Hayashi, N.; Iida, T.; Yamada, T.; Okuma, K.; Takehara, I.; Yamamoto, T.; Yamada, T.; Tokuda, M. Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects. Biosci. Biotechnol. Biochem. 2010, 74, 510–519. [CrossRef]

12. Iida, T.; Yamada, T.; Hayashi, N.; Okuma, K.; Izumori, K.; Ishii, R.; Matsuo, T. Reduction of abdominal fat accumulation in rats by 8-week ingestion of a newly developed sweetener made from high fructose corn syrup. Food Chem. 2013, 138, 781–785. [CrossRef]

13. Ochiai, M.; Nakanishi, Y.; Yamada, T.; Iida, T.; Matsuo, T. Inhibition by dietary D-psicose of body fat accumulation in adult rats fed a high-sucrose diet. Biosci. Biotechnol. Biochem. 2013, 77, 1123–1126. [CrossRef]

14. Choi, B.R.; Kwon, E.Y.; Kim, H.J.; Choi, M.S. Role of Synbiotics Containing D-Allulose in the Alteration of Body Fat and Hepatic Lipids in Diet-Induced Obese Mice. Nutrients 2018, 10, 1797. [CrossRef]

15. Hayashi, N.; Yamada, T.; Takamine, S.; Iida, T.; Okuma, K.; Tokuda, M. Weight reducing effect and safety evaluation of rare sugar syrup by a randomized double-blind.; parallel-group study in human. J. Funct. Foods 2014, 11, 152–159. [CrossRef]

16. Han, Y.; Kwon, E.Y.; Yu, M.K.; Lee, S.J.; Kim, H.J.; Kim, S.B.; Kim, Y.H.; Choi, M.S. A Preliminary Study for Evaluating the Dose-Dependent Effect of D-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2018, 10, 160. [CrossRef]

17. Hargreaves, M.; Spriet, L.L. Skeletal muscle energy metabolism during exercise. Nat. Metab. 2020, 2, 817–828. [CrossRef] [PubMed]

18. Hargreaves, M.; Spriet, L.L. Exercise Metabolism: Fuels for the Fire. Cold Spring Harb. Perspect. Med. 2018, 8, a029744. [CrossRef]

19. Hearris, M.A.; Hammond, K.M.; Fell, J.M.; Morton, J.P. Regulation of Muscle Glycogen Metabolism during Exercise: Implications for Endurance Performance and Training Adaptations. Nutrients 2018, 10, 298. [CrossRef] [PubMed]

20. Chin, E.R.; Allen, D.G. Effects of reduced muscle glycogen concentration on force; Ca2+ release and contractile protein function in intact mouse skeletal muscle. J. Physiol. 1997, 498 Pt 1, 17–29. [CrossRef] [PubMed]

21. Ishihara, K.; Taniguchi, H. Fat max as an index of aerobic exercise performance in mice during uphill running. PLoS ONE 2018, 13, e0193470. [CrossRef]

22. Yoon, H.J.; Spinelli, J.B.; Zaganjor, E.; Wong, S.J.; German, N.J.; Randall, E.C.; Dean, A.; Clermont, A.; Paulo, J.A.; Garcia, D.; et al. PHD3 Loss Promotes Exercise Capacity and Fat Oxidation in Skeletal Muscle. Cell Metab. 2020, 32, 215–228. [CrossRef] [PubMed]

23. Matsuo, T. Effects of daily intake of the rare sugar D-psicose on liver and muscle glycogen repletion with D-fructose administration after exhaustive swimming. BioTechnology 2011, 5, 290–292.

24. Nagata, Y.; Kanasaki, A.; Tamaru, S.; Tanaka, K. D-psicose, an epimer of D-fructose. favorably alters lipid metabolism in Sprague-Dawley rats. J. Agric. Food Chem. 2015, 63, 3168–3176. [CrossRef] [PubMed]

25. Kimura, T.; Kanasaki, A.; Hayashi, N.; Yamada, T.; Iida, T.; Nagata, Y.; Okuma, K. D-Allulose enhances postprandial fat oxidation in healthy humans. Nutrition 2017, 43–44, 16–20. [CrossRef]

26. Goh, J.; Ladiges, W. Voluntary Wheel Running in Mice. Curr. Protoc. Mouse Biol. 2015, 5, 283–290. [CrossRef]

27. Pauly, M.; Assense, A.; Rondon, A.; Thomas, A.; Dubouchaud, H.; Freyssenet, D.; Benoit, H.; Castells, J.; Flore, P. High intensity aerobic exercise training improves chronic intermittent hypoxia-induced insulin resistance without basal autophagy modulation. Sci. Rep. 2017, 7, 43663. [CrossRef]

28. Nishida, Y.; Nawaz, A.; Kado, T.; Takikawa, A.; Igarashi, Y.; Onogi, Y.; Wada, T.; Sasaoka, T.; Yamamoto, S.; Sasahara, M. Astaxanthin stimulates mitochondrial biogenesis in insulin resistant muscle via activation of AMPK pathway. J. Cachexia Sarcopeni. 2020, 11, 241–258. [CrossRef]

29. Tappe-Theodor, A.; King, T.; Morgan, M.M. Pros and Cons of Clinically Relevant Methods to Assess Pain in Rodents. Neurosci. Biobehav. Rev. 2019, 100, 335–343. [CrossRef]

30. Li, P.; Koike, T.; Qin, B.; Kubota, M.; Kawata, Y.; Jia, Y.J.; Oshida, Y. A high-fructose diet impairs Akt and PKCzeta phosphorylation and GLUT4 translocation in rat skeletal muscle. Horm. Metab. Res. 2008, 40, 528–532. [CrossRef] [PubMed]

31. Vigh-Larsen, J.F.; Ortenblad, N.; Spriet, L.L.; Overgaard, K.; Mohr, M. Muscle Glycogen Metabolism and High-Intensity Exercise Performance: A Narrative Review. Sports Med. 2021, 51, 1855–1874. [CrossRef]

32. Kasuga, M.; Ogawa, W.; Ohara, T. Tissue glycogen content and glucose intolerance. J. Clin. Investig. 2003, 111, 1282–1284. [CrossRef]

33. Pederson, B.A.; Cope, C.R.; Schroeder, J.M.; Smith, M.W.; Irimia, J.M.; Thurberg, B.L.; DePaoli-Roach, A.A.; Roach, P.J. Exercise capacity of mice genetically lacking muscle glycogen synthase: In mice; muscle glycogen is not essential for exercise. J. Biol. Chem. 2005, 280, 17260–17265. [CrossRef] [PubMed]

34. Lopez-Soldado, I.; Guinovart, J.J.; Duran, J. Increased liver glycogen levels enhance exercise capacity in mice. J. Biol. Chem. 2021, 297, 100976. [CrossRef] [PubMed]

35. O’Neill, H.M.; Lally, J.S.; Galic, S.; Thomas, M.; Azizi, P.D.; Fullerton, M.D.; Smith, B.K.; Pulinilkunnil, T.; Chen, J.P.; Samaan, M.C.; et al. AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice. Diabetologia 2014, 57, 1693–1702. [CrossRef]

36. Lin, J.; Handschin, C.; Spiegelman, B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005, 1, 361–370. [CrossRef] [PubMed]

37. Marcinko, K.; Steinberg, G.R. The role of AMPK in controlling metabolism and mitochondrial biogenesis during exercise. Exp. Physiol. 2014, 99, 1581–1585. [CrossRef] [PubMed]

38. Abreu, P.; Mendes, S.V.D.; Leal-Cardoso, J.H.; Ceccatto, V.M. Anaerobic threshold employed on exercise training prescription and performance assessment for laboratory rodents: A short review. Life Sci. 2016, 151, 1–6. [CrossRef]

39. Allen, D.G.; Lamb, G.D.; Westerblad, H. Skeletal muscle fatigue: Cellular mechanisms. Physiol. Rev. 2008, 88, 287–332. [CrossRef]

40. Yoshida, Y.; Jain, S.S.; McFarlan, J.T.; Snook, L.A.; Chabowski, A.; Bonen, A. Exercise- and training-induced upregulation of skeletal muscle fatty acid oxidation are not solely dependent on mitochondrial machinery and biogenesis. J. Physiol. 2013, 591, 4415–4426. [CrossRef]

41. Green, H.J.; Helyar, R.; Ball-Burnett, M.; Kowalchuk, N.; Symon, S.; Farrance, B. Metabolic adaptations to training precede changes in muscle mitochondrial capacity. J. Appl. Physiol. 1992, 72, 484–491. [CrossRef] [PubMed]

42. Iwasaki, Y.; Sendo, M.; Dezaki, K.; Hira, T.; Sato, T.; Nakata, M.; Goswami, C.; Aoki, R.; Arai, T.; Kumari, P.; et al. GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose. Nat. Commun. 2018, 9,13. [CrossRef] [PubMed]

43. Ochiai, M.; Onishi, K.; Yamada, T.; Iida, T.; Matsuo, T. D-psicose increases energy expenditure and decreases body fat accumulation in rats fed a high-sucrose diet. Int. J. Food Sci. Nutr. 2014, 65, 245–250. [CrossRef] [PubMed]

44. Shintani, H.; Shintani, T.; Ashida, H.; Sato, M. Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism. Nutrients 2018, 10, 1821. [CrossRef]

45. Hofer, S.J.; Davinelli, S.; Bergmann, M.; Scapagnini, G.; Madeo, F. Caloric Restriction Mimetics in Nutrition and Clinical Trials. Front. Nutr. 2021, 6, 717343. [CrossRef]

46. Ingram, D.K.; Roth, G.S. Glycolytic inhibition: An effective strategy for developing calorie restriction mimetics. Geroscience 2021, 43, 1159–1169. [CrossRef]

参考文献をもっと見る